[DOI] [PubMed] [Google Scholar] 70.A study of tirzepatide (LY3298176) compared with dulaglutide on major cardiovascular events in participants with type 2 diabetes (SURPASS-CVOT)
GLP-1 Medications Linked to Increased Hair Loss in New Study Heres How Much They Raise the Risk of Alopecia Researchers at the University of Pennsylvania published their findings on Wednesday, July 22 NEED TO KNOW A study from researchers at the University of Pennsylvania found GLP-1 medications are linked to a higher risk of hair loss, primarily non-scarring alopecia Hair loss cases remain rare, with 3 to 9 per 1,000 users annually, but may impact treatment decisions GLP-1 drugs, originally for type 2 diabetes, are now also widely used for weight management and appetite control A new study has linked the use of GLP-1s with increased hair loss
Provide updated scientific information
Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, et al
The menopause results come from a post-hoc analysis, meaning researchers went back and examined the trial data by menopausal status after the studies were completed
It is based on a larger Body Protection Compound originally found in human gastric juice